HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihiko Ito Selected Research

eviprostat

3/2013Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihiko Ito Research Topics

Disease

12Overactive Urinary Bladder (Overactive Bladder)
05/2019 - 08/2009
4Lower Urinary Tract Symptoms
05/2018 - 04/2009
3Cystitis
01/2014 - 01/2013
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2009 - 03/2009
2Interstitial Lung Diseases (Interstitial Lung Disease)
04/2021 - 04/2021
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2021 - 04/2021
1Pleural Effusion (Pleural Effusions)
04/2021
1Neoplasms (Cancer)
04/2021
1Hypothyroidism
04/2018
1Melanoma (Melanoma, Malignant)
04/2018
1Fatigue
01/2018
1Constipation
01/2018
1Erythema
01/2018
1Urinary Retention
01/2018
1Nocturia
01/2018
1Cognitive Dysfunction
09/2011
1Underactive Urinary Bladder
01/2010
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
02/2009
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
05/2008
1Pityriasis
05/2007

Drug/Important Bio-Agent (IBA)

9Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2014 - 08/2009
7Muscarinic AntagonistsIBA
01/2018 - 01/2010
5saw palmetto extractIBA
05/2018 - 03/2009
5imidafenacinIBA
01/2017 - 02/2011
5Cholinergic Agents (Cholinergics)IBA
01/2014 - 05/2008
4Solifenacin SuccinateFDA Link
01/2016 - 08/2009
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2014 - 05/2008
3NivolumabIBA
04/2021 - 04/2018
3Purinergic Receptors (Receptors, Purine)IBA
01/2014 - 05/2008
3CytokinesIBA
01/2014 - 01/2013
3oxybutynin (Tavor)FDA LinkGeneric
09/2012 - 08/2011
2Tolterodine Tartrate (Detrol)FDA Link
09/2012 - 08/2011
2Drug Receptors (Drug Receptor)IBA
08/2011 - 01/2010
1Monoclonal AntibodiesIBA
04/2021
1C-Reactive ProteinIBA
04/2021
1fesoterodineFDA Link
05/2019
1Carrier Proteins (Binding Protein)IBA
01/2019
1Cholinergic Antagonists (Anticholinergics)IBA
01/2019
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2019
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2018
1EnzymesIBA
04/2018
1Alkaline PhosphataseIBA
04/2018
1Alanine Transaminase (SGPT)IBA
04/2018
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2018
1Muscarinic M3 ReceptorIBA
01/2017
1Streptococcus pyogenes SpeA proteinIBA
01/2014
1eviprostatIBA
03/2013
1TeaIBA
01/2013
1Plant ExtractsIBA
01/2013
1gosha-jinki-ganIBA
01/2013
1Pharmaceutical PreparationsIBA
09/2011
1Prazosin (Minipress)FDA LinkGeneric
08/2011
1Tamsulosin (Flomax)FDA LinkGeneric
08/2011
1Adrenergic Receptors (Adrenergic Receptor)IBA
08/2011
1darifenacinFDA Link
08/2011
1silodosinFDA Link
08/2011
1propiverineIBA
08/2011
1distigmine (distigmine bromide)IBA
01/2010
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2010
1die-huang-wanIBA
08/2009
1HARNCAREIBA
08/2009
1Therapeutic UsesIBA
04/2009
11,4-dihydropyridine (dihydropyridine)IBA
04/2009
1Lauric AcidsIBA
04/2009
1Calcium Channels (Calcium Channel)IBA
04/2009
1Angiotensin IIIBA
02/2009
1Steryl-Sulfatase (Steroid Sulfatase)IBA
05/2007

Therapy/Procedure

2Therapeutics
01/2019 - 01/2018